Ketamine and Morphine Versus Morphine Alone for the Treatment of Acute Pain in the Emergency Department

July 11, 2023 updated by: University of Arizona

Our goal is to study whether giving people low dose ketamine along with morphine when they come to the Emergency Department will help their pain more than giving morphine by itself. There have been many studies showing that low dose ketamine is safe and effective for pain control. Ketamine is frequently used for pain control in ambulances and helicopters transporting injured patients to the hospital and has also been used for pain control in people who have just had surgery. The investigators would like to see if low dose ketamine would be safe and effective for patients with pain in the Emergency Department.

Patients are eligible for the study if they come to the Emergency Department and their treating physician decides to treat them with morphine (with certain exceptions such as pregnant patients and patients with eye injuries). They will be given information about participating in the study and if they agree, they will be given the study drug. The study drug will be either ketamine or salt water (saline). If patients continue to be in pain they will continue to receive doses of morphine just as they would if they were not in the study. If the treating physician feels that morphine alone is not enough, they will be free to choose another pain medication as they would normally.

Study Overview

Status

Terminated

Conditions

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Arizona
      • Tucson, Arizona, United States, 85724
        • University of Arizona Health Network University Campus 1501 North Campbell Ave

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Presenting to Emergency Department in acute pain
  • age 18 and over
  • determined to require morphine for pain control by treating physician

Exclusion Criteria:

  • Patients presenting with headache or head injury
  • Patient with eye injury or eye pain
  • Nontraumatic chest Pain
  • Pregnant patients or women of childbearing potential
  • Patients allergic to morphine or ketamine
  • Patients with known history of narcotic/alcohol abuse or presenting for narcotic medication refill
  • Patients with hypertension: diastolic blood pressure > 100 OR systolic blood pressure > 180
  • Patient whose pain is so severe that they are unable to give informed consent
  • Patients who have had bad experiences to prior hallucinations from any origin

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Morphine and placebo
Patient's will receive morphine during the usual course of their emergency department care and will receive a saline in a volume equivalent to the ketamine administered in the experimental arm of the stuy
Dosage of morphine determined by treating physician
saline of same volume as appropriate weight based dose of ketamine
Experimental: Morphine and Ketamine
Patient's will receive a 0.3mg/kg dose of ketamine in addition to morphine given in the usual course of emergency department care
Dosage of morphine determined by treating physician
0.3mg/kg ketamine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Score
Time Frame: Baseline (zero minutes), 30 minutes and 1 hour after receiving study drug
Pain 0-10 with 0 being no pain and 10 being the worst pain
Baseline (zero minutes), 30 minutes and 1 hour after receiving study drug

Secondary Outcome Measures

Outcome Measure
Time Frame
Total Amount of Morphine and Other Pain Medications Administered
Time Frame: Data collected from the duration of the patient's Emergency Department stay (expected average 5 hours)
Data collected from the duration of the patient's Emergency Department stay (expected average 5 hours)
Number of Participants With Adverse Events
Time Frame: Data collected from the duration of the patient's Emergency Department stay (expected average 5 hours)
Data collected from the duration of the patient's Emergency Department stay (expected average 5 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Berkman, M. R., Larsen, J., Smith, J., Caldwell, J., Waterbrook, A., Stolz, U., & Denninghoff, K. (2014). 369 Ketamine and Morphine versus Morphine Alone for Treatment of Acute Pain in the Emergency Department. Annals of Emergency Medicine, 64(4), S131-S132.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2013

Primary Completion (Actual)

April 1, 2014

Study Completion (Actual)

April 1, 2014

Study Registration Dates

First Submitted

July 8, 2013

First Submitted That Met QC Criteria

July 12, 2013

First Posted (Estimated)

July 17, 2013

Study Record Updates

Last Update Posted (Actual)

July 17, 2023

Last Update Submitted That Met QC Criteria

July 11, 2023

Last Verified

July 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Pain

Clinical Trials on Morphine

3
Subscribe